EU research projects

IDF Europe welcomes the opportunity to take an active role in EU-funded research and other initiatives that aim at improving the health of European citizens, as these contribute to finding new treatments for diabetes and improving the lives of people living with this condition.

Developed within the EU Seventh Framework Programme (FP7) and Horizon 2020 research and innovation programme, these projects encourage the development and validation of new therapies, methods for health promotion and prevention, as well as sustainable and efficient healthcare systems. IDF Europe is currently involved in the following projects: The Open projectCarpeDiab and Feel4diabetes. Past projects in which IDF Europe involved in were EConda, EUROCONDOR, Manage Care, JA-CHRODIS, EuRhythdia and ePredice

  • IDF Europe will participate in the Trials@home kick off meeting on 27-28 September

    IDF Europe is part of the Trials@Home consortium, a large-scale research project funded by the Innovative Medicines Initiative (IMI). During the project’s kick-off meeting which will take place in Paris, France on 27-28 September 2019, IDF Europe will discuss its role in dissemination and communication activities.

    In the upcoming five years the consortium, consisting of both public and private partners, will work together to reshape clinical trial designs and implementation in Europe. The aim is to operationalise remote decentralized clinical trials (RDCTs) in Europe so as to improve patients’ access to innovative treatment strategies.

    For more information, please read: https://www.imi.europa.eu/  

  • The OPEN project- Outcomes of Patients’ Evidence with Novel, Do-it-Yourself Artificial Pancreas Technology

    OPEN project logoIDF Europe is part of the OPEN project consortium, which establish an evidence-base surrounding the impact of Do-it-Yourself Artificial Pancreas Systems (DIY APS) on people with diabetes and wider healthcare systems. IDF Europe role is to facilitate the knowledge exchange by, among others hosting some scientific researchers and helping to disseminate the findings of the research..

    The OPEN project, launched in 2018, aims to examine clinical outcomes of those using DIY AP systems by analysing changes in quality and experiences of the users that will ultimately enable technological and predictive capacity improvements of the system.

    The novel feature of this project is the extent of public and patient involvement

    Contact our project officer Winne Ko to learn more on IDF Europe involvement in the project winne@idf-europe.org

    For more information, visit the OPEN project website: https://open-diabetes.eu/ 

     

     

  • CarpeDiab - Integrated e-health solution for self-management of type 2

    CarpediabCarpeDiab aims to be an advanced service for type 2 diabetes management. The project, which has received funding from the European Union's Horizon 2020, expects to have an impact on the behaviour of patients and the healthcare professionals to take full advantage of the possibility that technology opens.

    IDF Europe is part of the consortium that brings expertise from 6 European countries: Italy, The Netherlands, Turkey, Spain, Belgium and Germany, which leads it.

    CarpeDiab will continue its activity in 2019.  For more information, please visit: https://proempower-pcp.eu/pcp-contractors/carpediab.html

© 2019 International Diabetes Federation Disclaimer